Gujarat, India

Mrigendra Shukla

This inventor holds 1 USPTO granted patent. Top assignee: Cadila Healthcare Limited. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mrigendra Shukla. Retrieved from https://idiyas.com/inventor/mrigendra-shukla

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mrigendra Shukla: Innovator in Quinolone Based Compounds

Introduction

Mrigendra Shukla is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of quinolone based compounds. His work is aimed at improving processes that can lead to better treatment options for various health conditions.

Latest Patents

Mrigendra Shukla holds a patent for a process for the preparation of quinolone based compounds. This invention relates to an improved method for synthesizing these compounds using intermediate compounds. The compounds produced through this process can be utilized in treating anemia, showcasing the potential impact of his work on public health.

Career Highlights

Mrigendra Shukla is currently employed at Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His role involves research and development, where he focuses on innovative solutions to enhance drug efficacy and safety. His dedication to advancing medical science is evident in his patent and ongoing projects.

Collaborations

Mrigendra collaborates with talented professionals in his field, including coworkers Rakesh Chauhan and Ranjeet Nair. Their combined expertise contributes to the success of their projects and the advancement of pharmaceutical research at Cadila Healthcare Limited.

Conclusion

Mrigendra Shukla is a distinguished inventor whose work in quinolone based compounds has the potential to make a significant impact on healthcare. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…